Maduck Sean's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Mar 26, 2025
- Accession no.
- 0000950170-25-045431
- Filed
- Mar 26, 2025
- Trade date
- Mar 24, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $102.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maduck SeanCIK 0001698310 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | Common Stock | MOption exerciseAcquired | +1,697 | $5.05 | +$8,569.85 | 87,319 | Direct | |
| Mar 24, 2025 | Common Stock | SSaleDisposed | −1,697 | $60.58 | −$102,804.26 | 85,622 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | Common Stock | MOption exerciseDisposed | −1,697 | $0.00 | $0 | 121,986 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.